Secretome Therapeutics
Phase 1Secretome Therapeutics is a clinical-stage biotech company developing investigational neonatal cardiac progenitor cell (nCPC) therapies.
Founded
2018
Focus
Cell & Gene Therapy
About
Secretome Therapeutics is a clinical-stage biotech company developing investigational neonatal cardiac progenitor cell (nCPC) therapies.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile